Your browser doesn't support javascript.
loading
Development and validation of a metabolite index for obstructive sleep apnea across race/ethnicities.
Zhang, Ying; Ngo, Debby; Yu, Bing; Shah, Neomi A; Chen, Han; Ramos, Alberto R; Zee, Phyllis C; Tracy, Russell; Durda, Peter; Kaplan, Robert; Daviglus, Martha L; Rich, Stephen S; Rotter, Jerome I; Cai, Jianwen; Clish, Clary; Gerszten, Robert; Kristal, Bruce S; Gharib, Sina A; Redline, Susan; Sofer, Tamar.
Afiliação
  • Zhang Y; Division of Sleep Medicine and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
  • Ngo D; Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Cardiovascular Institute, Boston, MA, 02215, USA.
  • Yu B; Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
  • Shah NA; Department of Medicine, Albert Einstein College of Medicine, New York, NY, 10029, USA.
  • Chen H; Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
  • Ramos AR; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
  • Zee PC; Sleep Medicine Program, Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
  • Tracy R; Division of Sleep Medicine, Department of Neurology, Northwestern University, Chicago, IL, 60611, USA.
  • Durda P; Department of Pathology Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA.
  • Kaplan R; Department of Pathology Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA.
  • Daviglus ML; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
  • Rich SS; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 60612, USA.
  • Rotter JI; Center for Public Health Genomics, University of Virginia, Charlottesville, VA, 22908, USA.
  • Cai J; Department of Pediatrics, The Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, 90502, USA.
  • Clish C; Department of Biostatistics, Collaborative Studies Coordinating Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
  • Gerszten R; Metabolite Profiling Platform, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.
  • Kristal BS; Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Gharib SA; Department of Medicine, Sleep and Circadian Disorders, Harvard Medical School, Boston, MA, 02115, USA.
  • Redline S; Department of Medicine, Division of Sleep Medicine and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
  • Sofer T; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, 98195, USA.
Sci Rep ; 12(1): 21805, 2022 12 16.
Article em En | MEDLINE | ID: mdl-36526671
ABSTRACT
Obstructive sleep apnea (OSA) is a common disorder characterized by recurrent episodes of upper airway obstruction during sleep resulting in oxygen desaturation and sleep fragmentation, and associated with increased risk of adverse health outcomes. Metabolites are being increasingly used for biomarker discovery and evaluation of disease processes and progression. Studying metabolomic associations with OSA in a diverse community-based cohort may provide insights into the pathophysiology of OSA. We aimed to develop and replicate a metabolite index for OSA and identify individual metabolites associated with OSA. We studied 219 metabolites and their associations with the apnea hypopnea index (AHI) and with moderate-severe OSA (AHI ≥ 15) in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (n = 3507) using two

methods:

(1) association analysis of individual metabolites, and (2) least absolute shrinkage and selection operator (LASSO) regression to identify a subset of metabolites jointly associated with OSA, which was used to develop a metabolite index for OSA. Results were validated in the Multi-Ethnic Study of Atherosclerosis (MESA) (n = 475). When assessing the associations with individual metabolites, we identified seven metabolites significantly positively associated with OSA in HCHS/SOL (FDR p < 0.05), of which four associations-glutamate, oleoyl-linoleoyl-glycerol (181/182), linoleoyl-linoleoyl-glycerol (182/182) and phenylalanine, were replicated in MESA (one sided-p < 0.05). The OSA metabolite index, composed of 14 metabolites, was associated with a 50% increased risk for moderate-severe OSA (OR = 1.50 [95% CI 1.21-1.85] per 1 SD of OSA metabolite index, p < 0.001) in HCHS/SOL and 55% increased risk (OR = 1.55 [95% CI 1.10-2.20] per 1 SD of OSA metabolite index, p = 0.013) in MESA, both adjusted for demographics, lifestyle, and comorbidities. Similar albeit less significant associations were observed for AHI. Replication of the metabolite index in an independent multi-ethnic dataset demonstrates the robustness of metabolomic-based OSA index to population heterogeneity. Replicated metabolite associations may provide insights into OSA-related molecular and metabolic mechanisms.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Aterosclerose Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apneia Obstrutiva do Sono / Aterosclerose Idioma: En Ano de publicação: 2022 Tipo de documento: Article